Home Healthcare Pharmaceuticals Anti Viral Drugs Market

Anti Viral Drugs Market Size, Share & Trends Analysis Report By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, RNAi Antisense Therapeutics, Capsid Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza, Respiratory Syncytial Virus), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 16, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
  7. North America Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
  8. Europe Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
  9. APAC Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
  10. Middle East and Africa Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
  11. LATAM Anti Viral Drugs Market Size Analysis
    1. Introduction
    2. Anti Viral Drugs Market Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
    3. Anti Viral Drugs Market Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
    4. Anti Viral Drugs Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy 
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2025-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
      3. Market Size & Forecast By Application 2025-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy 
  12. Competitive Landscape
    1. Anti Viral Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. F. Hoffmann-La Roche Ltd. (Switzerland )
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences, Inc. (US)
    3. Merck & Co., Inc. (US)
    4. Pfizer Inc. (US)
    5. AbbVie Inc. (US )
    6. Johnson & Johnson (US )
    7. Bristol Myers Squibb (US)
    8. Viatris Inc. (US)
    9. GSK plc (UK)
    10. Cipla Limited (India)
    11. Sun Pharmaceutical Industries Ltd. (India)
    12. Boehringer Ingelheim International GmbH (Germany)
    13. Teva Pharmaceutical Industries Ltd. (Israel)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Anti Viral Drugs Market Size and Forecast By Regions - 2022-2034 (USD USD Billion)

Table 2: Global Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 3: Global Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 4: Global Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 5: North America Anti Viral Drugs Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 6: North America Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 7: North America Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 8: North America Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 9: U.S. Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 10: U.S. Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 11: U.S. Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 12: Canada Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 13: Canada Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 14: Canada Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 15: Europe Anti Viral Drugs Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 16: Europe Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 17: Europe Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 18: Europe Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 19: U.K. Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 20: U.K. Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 21: U.K. Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 22: Germany Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 23: Germany Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 24: Germany Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 25: France Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 26: France Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 27: France Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 28: Spain Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 29: Spain Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 30: Spain Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 31: Italy Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 32: Italy Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 33: Italy Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 34: Russia Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 35: Russia Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 36: Russia Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 37: Nordic Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 38: Nordic Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 39: Nordic Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 40: Benelux Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 41: Benelux Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 42: Benelux Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 43: Rest of Europe Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 44: Rest of Europe Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 45: Rest of Europe Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 46: APAC Anti Viral Drugs Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 47: APAC Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 48: APAC Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 49: APAC Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 50: China Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 51: China Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 52: China Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 53: Korea Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 54: Korea Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 55: Korea Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 56: Japan Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 57: Japan Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 58: Japan Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 59: India Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 60: India Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 61: India Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 62: Australia Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 63: Australia Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 64: Australia Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 65: Taiwan Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 66: Taiwan Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 67: Taiwan Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 68: South East Asia Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 69: South East Asia Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 70: South East Asia Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 71: Rest of Asia-Pacific Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 72: Rest of Asia-Pacific Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 73: Rest of Asia-Pacific Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 74: Middle East and Africa Anti Viral Drugs Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 75: Middle East and Africa Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 76: Middle East and Africa Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 77: Middle East and Africa Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 78: UAE Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 79: UAE Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 80: UAE Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 81: Turkey Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 82: Turkey Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 83: Turkey Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 84: Saudi Arabia Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 85: Saudi Arabia Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 86: Saudi Arabia Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 87: South Africa Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 88: South Africa Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 89: South Africa Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 90: Egypt Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 91: Egypt Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 92: Egypt Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 93: Nigeria Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 94: Nigeria Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 95: Nigeria Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 96: Rest of MEA Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 97: Rest of MEA Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 98: Rest of MEA Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 99: LATAM Anti Viral Drugs Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 100: LATAM Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 101: LATAM Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 102: LATAM Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 103: Brazil Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 104: Brazil Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 105: Brazil Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 106: Mexico Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 107: Mexico Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 108: Mexico Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 109: Argentina Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 110: Argentina Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 111: Argentina Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 112: Chile Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 113: Chile Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 114: Chile Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 115: Colombia Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 116: Colombia Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 117: Colombia Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 118: Rest of LATAM Anti Viral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD USD Billion)

Table 119: Rest of LATAM Anti Viral Drugs Market Size and Forecast By Application - 2022-2034 (USD USD Billion)

Table 120: Rest of LATAM Anti Viral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.